Deva Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 8 Months
- Open Charges ₹ 2.00 Cr
About Deva Lifesciences
Deva Lifesciences Private Limited (DLPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 May 2023 (One year and eight months 27 days old ). Its registered office is in Ahmed Nagar, Maharashtra, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Abhijit Waghmare, Gurucharan Gandhi, Sanket Kotkar, and One other member serve as directors at the Company.
Company Details
-
Location
Ahmed Nagar, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U46497PN2023PTC220443
-
Company No.
220443
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 May 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Who are the key members and board of directors at Deva Lifesciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijit Waghmare
|
Additional Director | 29-May-2023 | Current |
|
Gurucharan Gandhi
|
Additional Director | 29-May-2023 | Current |
|
Sanket Kotkar
|
Additional Director | 29-May-2023 | Current |
|
Amol Ghorpade
|
Director | 09-May-2023 | Current |
Financial Performance of Deva Lifesciences.
Enhance accessibility to Deva Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deva Lifesciences?
Unlock access to Deva Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vaidika Pharma Private LimitedAbhijit Waghmare is a mutual person
-
Phoenix Medtech India Private LimitedGurucharan Gandhi is a mutual person
-
Greensia Llp
Amol Ghorpade is a mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Oct 2023 | State Bank Of India | ₹2.00 Cr | Open |
How Many Employees Work at Deva Lifesciences?
Unlock and access historical data on people associated with Deva Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deva Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deva Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.